ANA Patterns on HEp-2 Indirect Immunofluorescence
ANA patterns on HEp-2 cells are categorized into nuclear, cytoplasmic, and mitotic patterns, with the International Consensus on ANA Patterns (ICAP) defining 29 distinct patterns (AC-0 to AC-29) that provide critical diagnostic information beyond simple positive/negative results. 1, 2
Major Nuclear Patterns
Homogeneous Pattern (AC-1)
- Appearance: Uniform, diffuse nuclear staining throughout the entire nucleus
- Associated antibodies: Anti-dsDNA, anti-histone, anti-DNP
- Clinical associations: Systemic lupus erythematosus (SLE), drug-induced lupus, mixed connective tissue disease (MCTD)
- Caveat: Can be confused with AC-29 (nuclear envelope pattern), which requires expertise-level reporting 1, 3
Speckled Pattern (AC-4, AC-5)
- Appearance: Fine to coarse granular nuclear staining with variable distribution
- Most common pattern: Represents 73.30% of nuclear patterns 4
- Associated antibodies: Anti-Sm, anti-U1-RNP, anti-Ro/SSA, anti-La/SSB
- Clinical associations: SLE, Sjögren's syndrome, MCTD, undifferentiated connective tissue disease
- Note: Mixed speckled/homogeneous patterns (termed "quasi-homogeneous" by some) are associated with Sm and U1snRNP antibodies 3
Dense Fine Speckled 70 (DFS70/AC-2)
- Appearance: Dense, fine speckled pattern throughout interphase nuclei with characteristic dense chromatin staining in mitotic cells
- Critical distinction: This pattern is associated with absence of systemic autoimmune rheumatic disease 5
- Clinical utility: Detection of anti-DFS70 antibodies helps exclude systemic autoimmune disease in otherwise healthy individuals with positive ANA 5
- Challenge: Overlaps with both homogeneous and speckled patterns, requiring expertise-level identification 3
Centromere Pattern (AC-3)
- Appearance: 40-60 discrete speckles in interphase nuclei; characteristic bar-like staining of condensed chromosomes in mitotic cells
- Associated antibodies: Anti-CENP (centromere proteins)
- Clinical associations: Limited systemic sclerosis (CREST syndrome), primary biliary cholangitis
- Prevalence: 4.85% of nuclear patterns 4
- Strong association: Highly specific for systemic sclerosis 6
Nucleolar Pattern (AC-8, AC-9, AC-10)
- Appearance: Large, coarse speckles within nucleoli; can be homogeneous, clumpy, or punctate
- Associated antibodies: Anti-RNA polymerase III, anti-PM/Scl, anti-fibrillarin, anti-Th/To
- Clinical associations: Systemic sclerosis (especially diffuse cutaneous), inflammatory myopathies
- Prevalence: 8.74% of nuclear patterns 4
Nuclear Dots Pattern (AC-6, AC-7)
- Appearance: Few (1-10) or multiple (>10) discrete nuclear dots
- Associated antibodies: Anti-Sp100, anti-PML (primary biliary cholangitis), anti-p80 coilin
- Clinical associations: Primary biliary cholangitis, Sjögren's syndrome
- Prevalence: Multiple dots pattern at 0.72% 6
Cytoplasmic Patterns
Mitochondrial Pattern (AC-21)
- Appearance: Fine granular cytoplasmic staining, sparing the nucleus
- Associated antibodies: Anti-mitochondrial antibodies (AMA), particularly anti-PDH
- Clinical associations: Primary biliary cholangitis (>95% sensitivity)
- Prevalence: 0.80% of uncommon patterns 6
- Note: Cytoplasmic patterns more commonly appear as mixed patterns and show broader disease distributions 7
Reticular/AMA Pattern (AC-22)
- Appearance: Reticular cytoplasmic staining
- Prevalence: 0.7% of ANA-positive cases (most common rare pattern) 7
- Clinical associations: More frequently observed in metabolic or infectious diseases rather than autoimmune conditions
- Titer characteristics: Mainly low titers (≤1:320) 7
Discrete Dots Pattern (AC-23)
- Appearance: Discrete cytoplasmic dots
- Prevalence: 0.41% of ANA-positive cases 7
- Clinical associations: Similar to AC-22, more common in metabolic/infectious diseases with low titers 7
Rods and Rings Pattern (AC-25)
- Appearance: Rod-like and ring-like cytoplasmic structures
- Associated antibodies: Anti-IMPDH2
- Clinical associations: Hepatitis C treatment with ribavirin and interferon, autoimmune hepatitis
- Prevalence: 0.25% 7
Mitotic Patterns
Mitotic Spindle Apparatus (AC-26)
- Appearance: Staining of the mitotic spindle fibers during cell division
- Associated antibodies: Anti-NuMA, anti-HsEg5
- Clinical associations: Variable; higher titers show enrichment in autoimmune diseases 7
- Prevalence: 0.23% of ANA-positive cases, 0.89% of uncommon patterns 7, 6
- Titer-dependent significance: Higher titers more frequently associated with autoimmune disease 7
Centrosome Pattern (AC-27)
- Appearance: Two dots adjacent to metaphase plate in mitotic cells
- Associated antibodies: Anti-pericentrin, anti-ninein
- Clinical associations: Raynaud's phenomenon, Sjögren's syndrome
Nuclear Envelope Pattern (AC-29)
- Appearance: Smooth or punctate rim staining of nuclear envelope; includes five different components
- Associated antibodies: Anti-gp210, anti-Scl-70 (topoisomerase I), anti-lamin
- Clinical associations: Highly specific for systemic sclerosis (96.2% of AC-29 patients with SSc were anti-Scl-70 positive) 7
- Prevalence: 0.16% but largely confined to autoimmune diseases 7
- Titer characteristics: Often observed at high titers 7
- Critical caveat: Requires expertise-level reporting due to complexity and overlap with homogeneous pattern 3
Clinical Interpretation Algorithm
Step 1: Pattern Recognition
- Identify whether staining is nuclear, cytoplasmic, mitotic, or mixed
- Document specific pattern using ICAP nomenclature (AC-0 to AC-29) 1, 2
- Report both titer and pattern, as both provide diagnostic value 1
Step 2: Reflex Testing Based on Pattern
- Homogeneous pattern: Test for anti-dsDNA, anti-histone
- Speckled pattern: Test for anti-ENA panel (Sm, RNP, Ro/SSA, La/SSB)
- Centromere pattern: Confirm with anti-CENP antibodies
- Nucleolar pattern: Consider anti-RNA polymerase III, anti-Scl-70
- DFS70 pattern: Confirm with anti-DFS70 to exclude systemic autoimmune disease 5
- AC-29 pattern: Test for anti-Scl-70 in suspected systemic sclerosis 7
Step 3: Clinical Correlation
- High titers (≥1:640) in non-autoimmune conditions are associated with liver disorders and related complications 8
- Low titers (≤1:80) have limited clinical significance without supporting clinical features
- Rare patterns (AC-22, AC-23) at low titers are more common in metabolic/infectious diseases 7
- AC-29 and high-titer AC-26 are enriched in autoimmune diseases, particularly systemic sclerosis 7
Critical Pitfalls to Avoid
Do not report "ANA positive" without specifying the method used - IIFA results differ significantly from ELISA or multiplex assays 1
Do not ignore the DFS70 pattern - This pattern suggests absence of systemic autoimmune disease and can prevent unnecessary workup in healthy individuals 5
Do not confuse homogeneous with AC-29 - Nuclear envelope pattern requires expertise recognition and has distinct clinical associations with systemic sclerosis 3
Do not dismiss low-titer rare patterns - While AC-22 and AC-23 at low titers are often non-autoimmune, AC-29 even at moderate titers warrants evaluation for systemic sclerosis 7
Do not overlook mixed patterns - Quasi-homogeneous (mixed speckled/homogeneous) patterns are associated with specific antibodies (Sm, U1snRNP) 3
Do not assume all positive ANAs indicate autoimmune disease - Up to 25% of healthy individuals can be ANA-positive, and prevalence increases with age 1, 8
Recognize that cytoplasmic and mitotic patterns require equal attention - These patterns provide distinct diagnostic information and should not be dismissed as "negative ANA" 1